More Business Wire
View Older Stories View Newer Stories-
Essential Utilities Launches Third Annual Earth Day Celebration
-
ABK Wins ‘Brewery of the Year’ in Clean Sweep of Medals and Awards at the London Beer Competition 2024
-
Timothy Franks Appointed CEO of Jacobs Holding
-
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
-
Microsoft Copilot Aims to Help U.K. Firms Navigate Cloud
-
Samsung Develops Industry’s Fastest 10.7Gbps LPDDR5X DRAM, Optimized for AI Applications
-
Sphere Fluidics Appoints Edward Rayner as Non-Executive Director
-
Intel Brings AI-Platform Innovation to Life at the Olympic Games
-
4me and Vitality Unveil the Future of Autonomous Enterprise Service Management at SITS24
-
Cornerstone’s New Learning Fundamentals Solution Transforms Learning and Skilling at Mid-Sized Organizations
-
The New FLOOR ONE S7 FlashDry from Tineco with Effective Quick-Drying Function
-
Acre Impact Capital Announces the First Closing of its Export Finance Fund I
-
New Logi AI Prompt Builder Software: Fast, Fluent, Fluid AI Access, For Free
-
Swiss Life Asset Managers Completes Investment in Telecom Infrastructure Partners Joining InfraBridge as a Key Shareholder
-
euroAtlantic Announces Management Changes and New Capital Injection
-
Clearstream to invest in Digital Vault Services
-
Always on Connectivity With Fixed Wireless Access by Expereo
-
All Seas Capital Invests in Reducate EdTech Group to Accelerate Growth
-
Regula Now Offers Fully LED-Equipped Video Spectral Comparators
-
Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS
-
EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A.
-
Hunting PLC (“Hunting” or “the Company” or “the Group”) AGM and Q1 2024 Trading Update and Directorate Change
-
AFYREN Commits to Responsible Care® and Receives a Trophy in the "Societal" Category
-
APi Group Announces Pricing of Public Offering of Common Stock
-
CTP N.V. Notice of Q1-2024 Results
-
BenevolentAI: Publication of the Revised Agenda for the 2024 AGM
-
HAFNIA LIMITED: Award of Share Options to Primary Insiders
-
Swifto Expands into North Carolina with Acquisition of Wagz 'n Whiskerz
-
Liberty Tire Recycling Applauds Work of Largest Tire Crumb Rubber Study Conducted in U.S.
-
FPT Software Attains Gold Stevie® at 2024 Asia-Pacific Stevie® Awards for Innovation
-
Kolibri Global Energy Inc. Provides Update on 2023 Annual Filings
-
Asia Pacific’s IT, Business Services Market Delivers ‘Resurgent’ Q1, ISG Index™ Finds
-
ADTRAN Holdings, Inc. to Release First Quarter 2024 Earnings on May 6, 2024
-
Walmart Collaboration with The Jessica Simpson Collection Brings Boho-Chic to its Growing Fashion Assortment
-
Radial Equity Partners Announces New Partnership with Moss Motors and Rimmer Bros
-
ADDING MULTIMEDIA Five-Time World Gold Medalist Swimming Sensation Regan Smith and her Cat Roo Partner with Nulo
-
Silvaco Announces Expanded Partnership with Micron Technology
-
Rio Tinto releases first quarter production results
-
Vista Gold Corp. Files Feasibility Study Update for the Mt Todd Gold Project
-
Buenaventura Announces First Quarter 2024 Results for Production and Volume Sold per Metal
-
Liberty Energy Announces Quarterly Cash Dividend
-
News Media Canada Welcomes Budget 2024’s Support for Local Journalism Initiative
-
Buenaventura Cordially Invites You to Its First Quarter 2024 Earnings Conference Call
-
Oak Ridge National Laboratory Collaborates with IonQ to Drive Critical U.S. Infrastructure Improvements
-
Axway Software: Disclosure of Transactions in Own Shares
-
M-tron Industries, Inc. Elevates Linda Biles to Executive Vice President
-
I2Pure & Toppen Health Join Forces to Transform Water Disinfection
-
Equity Bancshares, Inc. First Quarter Results Highlighted by Record Net Interest Income and Net Interest Margin Expansion
-
Northern Trust Declares Quarterly Dividends on Common and Preferred Stock
-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)


